Non-Operative Management of Rectal Cancer

Moderator(s)

• 

  Karyn Stitzenberg, MD, MPH

  Professor
  University of North Carolina

  Disclosure(s): Merck, J&J, Pfizer, Viatris, Organon, Vertex, Cigna, UHC, CVS Aetna: Stocks (Ongoing)
• 

  Nader Hanna, MD

  Professor of Surgery, Director of Clinical Operations, Division of General & Oncologic Surgery
  University of Maryland School of Medicine
  Baltimore, Maryland, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 4:31 PM – 4:41 PM

  Implementing a Watch and Wait Program
  

  Presenter: Matthew Kalady, MD (he/him/his) – The Ohio State University and James Comprehensive Cancer Center
• 4:42 PM – 4:52 PM

  Managing a Near Complete Response
  

  Presenter: Geerard Beets, Professor of Surgery (he/him/his) – The Netherlands Cancer Institute
• 4:53 PM – 5:03 PM

  Optimal Neoadjuvant Regimens
  

  Presenter: David Ryan, MD – Masscahusetts General Hospital
• 5:04 PM – 5:14 PM

  Immunotherapy for MMR-D Rectal Cancer
  

  Presenter: Martin R. Weiser, MD – Memorial Sloan Kettering Cancer Center
• 5:15 PM – 5:30 PM

  Questions and Discussions
  

  Panelist: Matthew Kalady, MD (he/him/his) – The Ohio State University and James Comprehensive Cancer Center

  Panelist: Geerard Beets, Professor of Surgery (he/him/his) – The Netherlands Cancer Institute

  Panelist: David Ryan, MD – Masscahusetts General Hospital

  Panelist: Martin R. Weiser, MD – Memorial Sloan Kettering Cancer Center